Cargando…
Reciprocal regulation of CIP2A and AR expression in prostate cancer cells
Cancerous inhibitor of protein phosphatase 2A (CIP2A) is an oncoprotein overexpressed in human malignancies, including prostate cancer (PCa). In this study, we aimed to explore the oncogenic function of CIP2A in PCa cells and its underlying mechanism. We showed that 63.3% (38/60 cases) of PCa tissue...
Autores principales: | Chuang, Hao-Wen, Pan, Jian-Hua, Cai, Yi-Xuan, Rupa, Darius, Huang, Ting-Syuan, Kuo, Tzu-Chien, Lin, Chiao-Wen, Chen, Chi-Wei, Lin, Chia-Chin, Lee, Herng-Sheng, Yuan, Ta-Chun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9470804/ https://www.ncbi.nlm.nih.gov/pubmed/36098827 http://dx.doi.org/10.1007/s12672-022-00552-8 |
Ejemplares similares
-
Characterization of a novel androgen receptor (AR) coregulator RIPK1 and related chemicals that suppress AR-mediated prostate cancer growth via peptide and chemical screening
por: Hsu, Cheng-Lung, et al.
Publicado: (2017) -
The reciprocal regulation loop of Notch2 pathway and miR-23b in controlling gastric carcinogenesis
por: Huang, Tzu-Ting, et al.
Publicado: (2015) -
CIP2A overexpression in Taiwanese oral cancer patients
por: Velmurugan, Bharath Kumar, et al.
Publicado: (2019) -
CIP2A expression is increased in prostate cancer
por: Vaarala, Markku H, et al.
Publicado: (2010) -
ER stress‐related ATF6 upregulates CIP2A and contributes to poor prognosis of colon cancer
por: Liu, Chun‐Yu, et al.
Publicado: (2018)